✦ LIBER ✦

Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease. A Pilot Study

✍ Scribed by Yago González-Lama; Luis Abreu; Maria Isabel Vera; Miguel Pastrana; Susana Tabernero; Juan Revilla; Juan Gómez Durán; Pedro Escartin

Book ID: 110086311
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 192 KB
Volume: 11
Category: Article
ISSN: 1078-0998
DOI: 10.1097/00054725-200501000-00002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term oral tacrolimus in refractory

Long-term oral tacrolimus in refractory to infliximab fistulizing Crohn’s disease: Comments from Spanish experience

✍ Yago González Lama 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 67 KB

P168 Long-term outcome of fistulizing Cr

P168 Long-term outcome of fistulizing Crohn's disease treated with infliximab a 12 years follow up study

✍ J. Florholmen; C. Dahl; R. Rismo; R. Goll 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 52 KB

P083 LOCAL INJECTION OF INFLIXIMAB IN CR

P083 LOCAL INJECTION OF INFLIXIMAB IN CROHN'S DISEASE RECURRENCE: A PILOT PROSPECTIVE LONGITUDINAL STUDY IN THE LONG-TERM

✍ L. Biancone; M. Cretella; C. Petruzziello; C. Tosti; S. Onali; E. Calabrese; G. 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 85 KB

P115 LONG-TERM EPISODIC INFLIXIMAB TREAT

P115 LONG-TERM EPISODIC INFLIXIMAB TREATMENT IN CROHN'S DISEASE. A DANISH CROHN COLITIS DATABASE STUDY

✍ N. Pedersen; S. Caspersen; C. Mortensen; M. Elkjær; L. Riis; V. Wewer; P. Munkho 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 60 KB

Cancer in Crohn's Disease patients treat

Cancer in Crohn's Disease patients treated with infliximab: A long-term multicenter matched pair study

✍ Livia Biancone; Carmelina Petruzziello; Ambrogio Orlando; Anna Kohn; Sandro Ardi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 2 views

## Background: The long-term risk of neoplasia in Crohn's disease (CD) patients treated with infliximab is undefined. The aim was to assess, in a multicenter, matched-pair study, whether infliximab use in CD is associated with an increased frequency of neoplasia in the long term. Methods: A multic

Open-label infliximab therapy in Crohn's

Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response

✍ Yago González-Lama; Antonio López-San Román; Ignacio Marín-Jiménez; Begoña Casis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 Spanish ⚖ 98 KB